Source: BioPortfolio

Oncology Plus: Avella Specialty Pharmacy acquires Oncology Plus

David SalazarAvella said that the acquisition would further its strategic vision to become the nation's leading omnisite specialty pharmacy and add breadth to its compounding and oncologyfocused capabilities and offerings. read more

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Zach Scholl's photo - President of Oncology Plus

President

Zach Scholl

CEO Approval Rating

69/100

Read more